NASDAQ · Price History

Aktis Oncology, Inc. (AKTS) Stock Price History & Returns

$16.31 NASDAQ: AKTS Market Cap $876.61M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Aktis Oncology, Inc. (AKTS) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $16.31 sits 12% of the way up a 52-week range of $13.96 to $34.19; 52.3% below the 52-week high; below its 50-day moving average of $18.74; below its 200-day average of $20.79; a beta of 0.45 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-33.5%
6 months-12.6%

Monthly closing prices

The last 11 months, newest first. 5 of 10 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$16.31+2.4%
October 2026$15.93-18.2%
September 2026$19.47-24.9%
August 2026$25.91+17.4%
July 2026$22.07-31.5%
June 2026$32.23+55.4%
May 2026$20.74+10.6%
April 2026$18.75+4.8%
March 2026$17.89-11.1%
February 2026$20.13-0.6%
January 2026$20.25—

Aktis Oncology, Inc. (AKTS) price history — frequently asked questions

How has Aktis Oncology, Inc. performed over the last year?

Aktis Oncology, Inc. (AKTS) has risen 0.0% over the last twelve months, measured on price alone.

What is Aktis Oncology, Inc.'s five-year return?

Over five years the AKTS share price has gained 0.0%, excluding dividends.

What is Aktis Oncology, Inc.'s 52-week range?

Over the last year Aktis Oncology, Inc. (AKTS) has traded between $13.96 and $34.19.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.